{
    "Rank": 263,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT01368744",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "OSNA-BC-002"
                },
                "Organization": {
                    "OrgFullName": "Sysmex America, Inc.",
                    "OrgClass": "INDUSTRY"
                },
                "BriefTitle": "Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology",
                "OfficialTitle": "Intraoperative Examination of Sentinel Lymph Nodes: Comparison of the OSNA Breast Cancer System to Extensive Frozen Section Histopathology"
            },
            "StatusModule": {
                "StatusVerifiedDate": "June 2011",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "March 2010"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "June 2011",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "June 2011",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "June 6, 2011",
                "StudyFirstSubmitQCDate": "June 6, 2011",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "June 8, 2011",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "June 6, 2011",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "June 8, 2011",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyOldNameTitle": "Carrie Pineda",
                    "ResponsiblePartyOldOrganization": "Sysmex America, Inc"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Sysmex America, Inc.",
                    "LeadSponsorClass": "INDUSTRY"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the OSNA Breast Cancer System by comparing its performance to an extensive intraoperative frozen section protocol for Sentinel Lymph Nodes removed during standard Sentinel Lymph Node biopsy procedures from breast cancer subjects."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Breast Neoplasms",
                        "Breast Diseases"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Breast Neoplasms",
                        "Breast Diseases"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Case-Only"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "BioSpec": {
                    "BioSpecRetention": "Samples With DNA",
                    "BioSpecDescription": "Samples of the tissue homogenate will be retained and may be used for for further testing."
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "150",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "OSNA Breast Cancer System",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Device: OSNA Breast Cancer System"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Device",
                            "InterventionName": "OSNA Breast Cancer System",
                            "InterventionDescription": "For in vitro diagnostic use only.\n\nThe OSNA Breast Cancer System is an automated semi-quantitative, in vitro diagnostic test for the rapid detection of greater than (>) 0.2 mm metastases in nodal tissue removed from sentinel lymph node biopsies of breast cancer patients. Results from the assay can be used to guide the intra-operative or post-operative decision to remove additional lymph nodes and to aid in patient staging. An assay positive + or ++ result indicates the presence of metastasis (> 0.2 mm). An assay positive ++ result predicts the presence of macrometastasis (> 2 mm).\n\nGroups: OSNA Breast Cancer System",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "OSNA Breast Cancer System"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Prospectively assess the concordance and performance of the OSNA Breast Cancer System with an extensive intraoperative frozen section protocol for SLNs removed using standard SLN biopsy procedures from breast cancer subjects.",
                            "PrimaryOutcomeTimeFrame": "3 months"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nMale or female;\n18 years of age or older;\nDiagnosed pre-surgically with T1 or T2 breast cancer without clinical evidence of axillary lymph node involvement and scheduled for surgery including sentinel lymph node dissection;\nSubjects (or the subjects' legal representatives) who have read, understood to the best of their ability and signed the informed consent form.\n\nExclusion Criteria:\n\nSubjects diagnosed pre-surgically with large or locally advanced (T3 & T4) breast cancer;\nPregnant subjects, confirmed by interview with either subject or treating physician;\nSubjects diagnosed with inflammatory breast cancer;\nSubjects diagnosed with ductal carcinoma in situ (DCIS) when breast conservation is to be done;\nSubjects with clinically suspicious, palpable axillary lymph nodes;\nSubjects previously treated for or previously diagnosed with another type of invasive cancer. Subjects with skin cancer (basal cell and squamous cell carcinoma) may be included, except for subjects diagnosed with melanoma; Subjects with non-invasive carcinoma of the Cervix may also be included in this study.\nSubjects who have received pre-operative systemic therapy;\nSubjects who are incapable of providing written informed consent;\nSubjects who have been judged to be an inappropriate candidate by any medical care provider (e.g., surgeon, oncologist or pathologist).\nSubjects participating in other clinical studies where the SLN evaluation will be negatively impacted by this study.",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "18 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Patients with a previous diagnosis of breast cancer scheduled for sentinel lymph node dissection.",
                "SamplingMethod": "Probability Sample"
            },
            "ContactsLocationsModule": {
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "University of Milan School of Medicine",
                            "LocationCity": "Milan",
                            "LocationZip": "435 - 20141",
                            "LocationCountry": "Italy"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001943",
                            "ConditionMeshTerm": "Breast Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000001941",
                            "ConditionMeshTerm": "Breast Diseases"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000012871",
                            "ConditionAncestorTerm": "Skin Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M4910",
                            "ConditionBrowseLeafName": "Breast Neoplasms",
                            "ConditionBrowseLeafAsFound": "Breast Neoplasms",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4908",
                            "ConditionBrowseLeafName": "Breast Diseases",
                            "ConditionBrowseLeafAsFound": "Breast Diseases",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M15364",
                            "ConditionBrowseLeafName": "Skin Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC17",
                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}